Krystal Biotech
KRYS
KRYS
244 hedge funds and large institutions have $5.24B invested in Krystal Biotech in 2024 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 100 increasing their positions, 71 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
244
Holders Change
+10
Holders Change %
+4.27%
% of All Funds
3.55%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.1%
New
51
Increased
100
Reduced
71
Closed
40
Calls
$54.5M
Puts
$42.2M
Net Calls
+$12.3M
Net Calls Change
+$40.3M
Top Buyers
| 1 |
BlackRock
New York
|
+$393M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$143M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$80.1M |
| 4 |
State Street
Boston,
Massachusetts
|
+$71.3M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$42.9M |
Top Sellers
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$89.5M |
| 2 |
Jennison Associates
New York
|
-$27.6M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$22.5M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$18.4M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$17.6M |
